Does cardiac rehabilitation improve left ventricular diastolic function of patients with acute myocardial infarction?

Rezzan Deniz Acar1, Mustafa Bulut2, Sunay Ergün2

  • 1Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital, İstanbul, Turkey. denizacar_1999@yahoo.com.

Insights

Cardiac rehabilitation (CR) significantly improves left ventricular diastolic function, specifically septal e

Area of Science:

  • Cardiology
  • Cardiovascular Rehabilitation
  • Diastolic Dysfunction

Background:

  • Acute myocardial infarction (AMI) and subsequent percutaneous coronary intervention (PCI) can impact left ventricular diastolic function.
  • Cardiac rehabilitation (CR) is a crucial component of post-MI care, but its specific effects on diastolic function require further elucidation.

Purpose of the Study:

  • To evaluate the impact of a cardiac rehabilitation (CR) program on left ventricular diastolic function in patients following acute myocardial infarction (AMI) and percutaneous coronary intervention (PCI).
  • To assess specific echocardiographic parameters of diastolic function, including mitral inflow velocities, tissue Doppler imaging, and pulmonary venous waveforms.

Main Methods:

  • A study involving 82 patients: 42 in a CR program and 40 in a control group.
  • Comprehensive echocardiographic assessments including mitral inflow (E/A ratio, deceleration time), tissue Doppler imaging (e'), and pulmonary venous flow patterns.
  • Calculation of E/e' ratio and measurement of isovolumic relaxation time (IVRT).

Main Results:

  • Patients in the CR group demonstrated significantly improved E/A ratio (p=0.048) and septal e' (p=0.006) compared to the control group.
  • No statistically significant difference was observed in E/e' between the groups (p=0.138).
  • Hypertension was significantly associated with the E/A ratio (p=0.000), while infarct-related artery status did not correlate with diastolic function.

Conclusions:

  • Cardiac rehabilitation (CR) leads to significant improvements in septal e' and E/A ratio in patients with AMI post-PCI.
  • These diastolic function improvements are particularly notable in hypertensive patients undergoing CR.
  • CR partially enhances left ventricular diastolic function in this patient population.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
920
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
499